Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, cancer, and to advance research in tissue engineering and regenerative medicines. The company has an established, robust pipeline of human-derived hydrogels for growing cells in 3D, adult human stem cells from a biobank of diverse populations, media for growing and differentiating cells, complete tissue chip kits, such as the on-market fat-on-chip and in-development pancreas-on-a-chip products. These kits provide an essential platform for drug discovery and development. When combined, these products provide research scientists in pharmaceutical companies, biotech, academia, and government laboratories with more accurate models that mimic the human condition and are allow for better understanding the pathology they are investigating. As a result, Obatala Sciences’ solutions drive improved drug success rates, while significantly decreasing the cost and time to bring therapeutics to market.